Humoral and cellular autoimmune responses in stiff person syndrome

Annals of the New York Academy of Sciences

Volumn 998, Issue , 2003, Pages 215-222

  Lohmann, Tobias ^a   Londei, Marco ^b   Hawa, Mohammed ^c   Leslie, R David G ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Autoimmune disease; Glutamic acid decarboxylase 65; Stiff person syndrome; Type 1 diabetes

Indexed keywords

AMINO ACID; ANTIGEN; AUTOANTIGEN; EPITOPE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4;

ADOLESCENT; ADULT; ALLELE; AMINO ACID ANALYSIS; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HLA SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; STIFF MAN SYNDROME; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0141727695     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1254.024     Document Type: Conference Paper

References (36)

1. BU, D-F., M.G. ERLANDER, B.C. HITZ et al. 1989. Two human glutamate decarboxylases, 65-kD and 67-kD GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. USA 89: 2115-2119.
2. BAEKKESKOV, S., H-J. AANSTOOT, S. CHRISTGAU et al. 1990. Identification of the 64 K autoantigen in insulin-dependent diabetes mellitus as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156.
3. r isoform of glutamic acid decarboxylase. Diabetes 42: 631-636.
4. SOLIMENA, M., F. FOLLI, S. DENIS-DONINI et al. 1988. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type-1 diabetes. N. Engl. J. Med. 318: 1012-1020.
5. MOERSCH, F.P. & H.W. WOLTMAN. 1957. Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome): report of a case and some observations in 13 other cases. Mayo Clin. Proc. 31: 421-427.
6. LI, L., W.A. HAGOPIAN, H.R. BRASHEAR et al. 1994. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 152: 930-934.
7. 65 distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. J. Exp. Med. 180: 595-606.
8. YOON, J.W., C.S, YOON, H.W. LIM et al. 1999. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284: 1183-1187.
9. SOLIMENA, M., F. FOLLI, R. APARISI et al. 1990. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 322: 1555-1560.
10. DINKEL, K., H.M. MEINCK, K.M. JURY et al. 1998. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 44: 194-201.
11. MILLWARD, B.A., M.J. HUSSAIN, M. PEAKMAN et al. 1988. Characterisation of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality. Clin. Exp. Immunol. 71: 353-366.
12. ABBAS, A.K., K.M. MURPHY & A. SHER. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787-793.
13. MADEC, A-M., F. ROUSSET, S. HO et al. 1996. Four IgG anti-islet human monoclonal antibodies isolated from a type 1 diabetes patient recognize distinct epitopes of glutamic acid decarboxylase. J. Immunol. 156: 3541-3549.
14. RICHTER, W., Y. SHI & S. BAEKKESKOV. 1993. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc. Natl. Acad. Sci. USA 90: 2832-2836.
15. BUTLER, M.H., M. SOLIMENA, R. DIRKX et al. 1993. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J. Exp. Med. 178: 2097-2106.
16. BJÖRK, E., L.A. VELLOSO, O. KÄMPE & F.A. KARLSSON. 1993. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type 1 recognize different epitopes. Diabetes 43: 161-165.
17. LOHMANN, T., R.D.G. LESLIE, M. HAWA et al. 1994. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet 343: 1607-1608.
18. ATKINSON, M.A., M.A. BOWMAN, L. CAMPBELL et al. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94: 2125-2129.
19. HAWA, M., R. ROWE, M.S. LAN et al. 1997. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46: 1270-1275.
20. HAWA, M.I., D. FAVA, F. MEDICI et al. 2000. Antibodies to IA2 and GAD65 in type 1 and type 2; isotype restriction and polyclonality. Diab. Care 23: 228-233.
21. REECE, J.C., H.M. GEYSEN & S.J. RODDA. 1993. Mapping the major human T helper epitopes of tetanus toxin. J. Immunol. 151: 6175-6184.
22. PICARD, J. 1993. Single-step allele-specific polymerase chain reaction HLA-DQ subtyping using ARMS primers. Hum. Immunol. 38: 115-122.
23. ENDL, J., H. OTTO, G. JUNG et al. 1997. Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J. Clin. Invest. 99: 2405-2415.
24. WICKER, L.S., S.L. CHEN, G.T. NEPOM et al. 1996. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRBI*0401. J. Clin. Invest. 98: 2597-2603.
25. BACH, J-M., H. OTTO, G.T. NEPOM et al. 1997. High affinity presentation of an auto-antigenic peptide in type 1 diabetes by an HLA class II protein encoded in a haplo-type protecting from disease. J. Autoimmun. 10: 375-386.
26. SCHLOOT, N.C., M.C. BATSTRA, G. DUINKERKEN et al. 1999. GAD65-reactive T cells in a non-diabetic stiff-man syndrome patient. J. Autoimmun. 12: 289-296.
27. HIEMSTRA, H.S., N.C. SCHLOOT, P.A. VAN VEELEN et al. 2001. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA 98: 3988-3991.
28. TIAN, J. & D.L. KAUFMAN. 1998. Attenuation of inducible Th2 immunity with autoimmune disease progression. J. Immun. 161: 5399-5403.
29. KALLMANN, B.A., M. HUTHER, M. TUBES et al. 1997. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 46: 237-243.
30. DILTS, S.M. & K.J. LAFFERTY. 1999. Autoimmune diabetes: the involvement of benign and malignant autoimmunity. J. Autoimmun. 12: 229-232.
31. PUGLIESE, A., R. GIANANI, G.S. EISENBARTH et al. 1994. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiff-man syndrome. Lancet 344: 1027-1028.
32. KUKREJA, A., G. COST, J. MARKER et al. 2002. Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131-140.
33. RABINOVITCH, A. 1994. Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: therapeutic intervention by immunostimulation? Diabetes 44: 859-862.
34. LOHMANN, T., S. LAUE, U. NIETZSCHMANN et al. 2002. Reduced expression of Th1 associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 51: in press.
35. ELLIS, T.M. & M.A. ATKINSON. 1996. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nat. Med. 2: 148-153.
36. LIBLAU, R.S., S.M. SINGER & H.O. MCDEVITT. 1995. TH1 and TH2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16: 34-38.